EUVIMEDEUVIMED entdecken
Crossref

Asiaticoside enhances the anti-tumor effect of anti-PDL1 by regulating T cell activity through increasing LCK activity

Qingyi Ren, Fang Wang, Fei Du, Chenxi He, Xiaodong Wang, Jun Wang, Zhuo Zhang, Yuhong Sun

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Qingyi Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Triterpenes, T-Lymphocytes, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Carcinoma, Hepatocellular. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-PD-L1 antibody confers anti-tumor effects, but its long-term use can provoke resistance and adverse effects. Asiaticoside, a bioactive triterpene glycoside from Centella asiatica L., regulates immune function and induces apoptosis of hepatocellular carcinoma (HCC) cells. T cells play a vital role in killing tumor cells and require lymphocyte-specific protein tyrosine kinase (LCK) for activation. Here, we examined whether a combined asiaticoside and anti-PD-L1 treatment regulates T cells via LCK activation to enhance the anti-tumor effect in vivo. We established a subcutaneous mouse HCC model using Hepa1-6 cells and measured spleen and tumor weight. Morphological changes of tumor tissues were assessed by hematoxylin-eosin staining. Tumor cell apoptosis and proliferation were determined by TUNEL staining and KI67 immunohistochemistry. The proportion of activated T cells in the spleen was detected by flow cytometry, and the levels of phosphorylated p-LCK and p-AKT in the spleen were determined by Western blotting. Changes in the levels of serum inflammatory factors were detected with ELISA. Our results revealed that the combined asiaticoside and anti-PD-L1 treatment inhibited tumor growth by enhancing apoptosis and reducing tumor cell proliferation. The treatment activated T cells to increase the proportion of effector T cells in the spleen, evidenced by upregulated p-LCK and p-AKT levels. It also increased the level of TNF-α in the serum and decreased IL-6, implying an enhanced immune response. In conclusion, the combined asiaticoside and anti-PD-L1 treatment enhances the anti-HCC effect in vivo by promoting LCK activation to regulate T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesT-LymphocytesLymphocyte Specific Protein Tyrosine Kinase p56(lck)Carcinoma, HepatocellularB7-H1 AntigenLiver NeoplasmsImmune Checkpoint InhibitorsAnimalsMiceApoptosisCell Line, TumorCell ProliferationMice, Inbred BALB CLymphocyte ActivationHumans

Stichwörter der Autor:innen

Anti-PDL1AsiaticosideHepatocellular carcinomaLymphocyte-specific protein tyrosine kinase (LCK)T cell

Substanzen

asiaticosideTriterpenesLymphocyte Specific Protein Tyrosine Kinase p56(lck)B7-H1 AntigenImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou, China; Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China…
  • Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Department of Hepatobiliary Disease, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou, China; Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China. Electronic address: zhuozhang@swmu.edu.cn.

Förderung

  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Ren, Q., Wang, F., Du, F., He, C., Wang, X., Wang, J., Zhang, Z., & Sun, Y. (2025). Asiaticoside enhances the anti-tumor effect of anti-PDL1 by regulating T cell activity through increasing LCK activity. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155995

Vancouver

Ren Q, Wang F, Du F, He C, Wang X, Wang J, et al. Asiaticoside enhances the anti-tumor effect of anti-PDL1 by regulating T cell activity through increasing LCK activity. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155995

BibTeX
@article{Ren2025,
  author = {Ren, Qingyi and Wang, Fang and Du, Fei and He, Chenxi and Wang, Xiaodong and Wang, Jun and Zhang, Zhuo and Sun, Yuhong},
  title = {Asiaticoside enhances the anti-tumor effect of anti-PDL1 by regulating T cell activity through increasing LCK activity},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155995}
}
Kostenlos starten →